Literature DB >> 28087253

What is an "ideal" antibiotic? Discovery challenges and path forward.

Sheo B Singh1, Katherine Young2, Lynn L Silver3.   

Abstract

An ideal antibiotic is an antibacterial agent that kills or inhibits the growth of all harmful bacteria in a host, regardless of site of infection without affecting beneficial gut microbes (gut flora) or causing undue toxicity to the host. Sadly, no such antibiotics exist. What exist are many effective Gram-positive antibacterial agents as well as broad-spectrum agents that provide treatment of certain Gram-negative bacteria but not holistic treatment of all bacteria. However effectiveness of all antibacterial agents is being rapidly eroded due to resistance. This viewpoint provides an overview of today's antibiotics, challenges and potential path forward of discovery and development of new (ideal) antibiotics.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibacterials; Antibiotics; Discovery challenges; ESKAPE; Path-forward of discovery

Mesh:

Substances:

Year:  2017        PMID: 28087253     DOI: 10.1016/j.bcp.2017.01.003

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  39 in total

1.  An Aminoglycoside Antibacterial Substance, S-137-R, Produced by Newly Isolated Bacillus velezensis Strain RP137 from the Persian Gulf.

Authors:  Roya Pournejati; Ronald Gust; Hamid Reza Karbalaei-Heidari
Journal:  Curr Microbiol       Date:  2019-06-11       Impact factor: 2.188

Review 2.  Antibiotic Hybrids: the Next Generation of Agents and Adjuvants against Gram-Negative Pathogens?

Authors:  Ronald Domalaon; Temilolu Idowu; George G Zhanel; Frank Schweizer
Journal:  Clin Microbiol Rev       Date:  2018-03-14       Impact factor: 26.132

Review 3.  Essential Two-Component Systems Regulating Cell Envelope Functions: Opportunities for Novel Antibiotic Therapies.

Authors:  Silvia T Cardona; Matthew Choy; Andrew M Hogan
Journal:  J Membr Biol       Date:  2017-11-02       Impact factor: 1.843

Review 4.  The challenge of converting Gram-positive-only compounds into broad-spectrum antibiotics.

Authors:  Michelle F Richter; Paul J Hergenrother
Journal:  Ann N Y Acad Sci       Date:  2018-02-15       Impact factor: 5.691

5.  Semimechanistic Modeling of Eravacycline Pharmacodynamics Using In Vitro Time-Kill Data with MIC Incorporated in an Adaptive Resistance Function.

Authors:  Ken Nguyen; Timothy J Bensman; Xiaohui Tracey Wei; Jason N Moore
Journal:  Antimicrob Agents Chemother       Date:  2020-08-20       Impact factor: 5.191

Review 6.  Comparison of Strategies to Overcome Drug Resistance: Learning from Various Kingdoms.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2018-06-18       Impact factor: 4.411

7.  A combination of photodynamic therapy and antimicrobial compounds to treat skin and mucosal infections: a systematic review.

Authors:  Vanesa Pérez-Laguna; Yolanda Gilaberte; María Isabel Millán-Lou; Montserrat Agut; Santi Nonell; Antonio Rezusta; Michael R Hamblin
Journal:  Photochem Photobiol Sci       Date:  2019-05-15       Impact factor: 3.982

Review 8.  Development of coinage metal nanoclusters as antimicrobials to combat bacterial infections.

Authors:  Dan Li; Beena Kumari; Jessa Marie Makabenta; Bailong Tao; Kun Qian; Xifan Mei; Vincent M Rotello
Journal:  J Mater Chem B       Date:  2020-10-28       Impact factor: 6.331

9.  Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections.

Authors:  Christopher H Goss; Yukihiro Kaneko; Lisa Khuu; Gail D Anderson; Sumedha Ravishankar; Moira L Aitken; Noah Lechtzin; Guolin Zhou; Daniel M Czyz; Kathryn McLean; Oyebode Olakanmi; Howard A Shuman; Mary Teresi; Ellen Wilhelm; Ellen Caldwell; Stephen J Salipante; Douglas B Hornick; Richard J Siehnel; Lev Becker; Bradley E Britigan; Pradeep K Singh
Journal:  Sci Transl Med       Date:  2018-09-26       Impact factor: 17.956

Review 10.  Brief Overview of Approaches and Challenges in New Antibiotic Development: A Focus On Drug Repurposing.

Authors:  Natalie K Boyd; Chengwen Teng; Christopher R Frei
Journal:  Front Cell Infect Microbiol       Date:  2021-05-17       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.